pharmacology and pharmacy
1,241 projects
pharmaceutical drugs671drug discovery338drug resistance254pharmacokinetics43adverse drug reactions6drug safety4
HEIndividual fellowship2027–2029France
JAK2-TB · Human JAK2 genotypes underlying tuberculosis
3 partners
HEDoctoral network2027–2031Spain
ReCoTA · Reconfigurable Colloids For Therapeutic Applications
20 partners · 9 countries
HEDoctoral network2027–2031United Kingdom
RADICALLY · Enantioselective Catalysis for Radical Transformations
13 partners · 6 countries
HEIndividual fellowship2027–2029Ireland
AURa · Antibacterial and pro-Angiogenic electroconductive scaffold for functional woUnd Regen-eration with neurogenic cues
HEIndividual fellowship2027–2028France
ProSAR · Role of prophages in the evolution and spread of antiviral resistance in Pseudomonas aeruginosa
HEIndividual fellowship2027–2029Sweden
SHINE-Vax · Smart Hydrogel Microneedle Patches for mRNA Nanoparticle Vaccination
HEIndividual fellowship2027–2029Finland
UNFENCED · Unravelling Nanoplastics: The Fate of Emerging Contaminants and Nanoplastics Concomitance in Environmental Dynamics
HEIndividual fellowship2027–2029Austria
SelenoResist · Targeting selenocysteine metabolism as a novel vulnerability in refractory non-small-cell lung cancer
HEIndividual fellowship2027–2029Spain
PINCLUS · Chaotropic transmembrane delivery of proteins
HEIndividual fellowship2027–2030Germany
EvoComb · Evolution under sequential antibiotic combinations: integrating clinical data into models and experiments to tackle resistance
3 partners · 3 countries
HEIndividual fellowship2027–2028Denmark
IRGOP · Immunometabolic Reprogramming via a Gut-derived Organoid Platform
HEIndividual fellowship2027–2028Austria
GlycoIMPACT · Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies
2 partners · 2 countries
HEIndividual fellowship2027–2029Spain
CLUSTERS · Controlling Polymorphism Using Optimal Electric Fields
HEStaff exchange2027–2030Norway
BIOVIRAL · Biofuel-based Innovation for the Optimization of VIRAL inhibition through alcohol-ligand modeling
3 partners · 3 countries
HEIndividual fellowship2027–2029Spain
PlasPhage · When plasmids meet phages (PlasPhage): Unveiling Mobile Genetic Element conflicts in carbapenem-resistant enterobacteria
2 partners
HEIndividual fellowship2027–2029Spain
INFECTAR · Integrating multidisciplinary frameworks and empirical data to capture transmission dynamics of antibiotic resistance
2 partners · 2 countries
HEIndividual fellowship2027–2029Switzerland
TROJAN NRPS-RiPP · Genome Mining-Based Discovery and Engineering of Trojan Horse Peptide Antibiotics Against Gram-Negative Pathogens
HEIndividual fellowship2027–2029Denmark
SCRIPT · Developing next-generation genetic reporters for detecting horizontal gene transfer
2 partners · 2 countries
HEIndividual fellowship2027–2029Sweden
DYNAMITE · Dynamic Mapping of Mitochondrial Translation Initiation and Elongation
2 partners · 2 countries
HEIndividual fellowship2027–2029Italy
MCG-QUAD · Machine Learning-Enhanced Coarse-Grained Modelling of Telomeric G-Quadruplex Multimers: A Multiscale Study
HEIndividual fellowship2026–2029Germany
GPMVreconstituteEGFR · EGFR protein condensation as a regulator of Ras activity
2 partners · 2 countries
HEDoctoral network2026–2030Slovenia
LLIMIT · Lectin ligands for modulation of immunity
13 partners · 8 countries
HEDoctoral network2026–2030Greece
ANA-KIN · Advancing Novel Approaches in Kinase Interface Networks
20 partners · 10 countries
HEIndividual fellowship2026–2028France